Armed robbery in Revesby1 小时
FDA OKs Pfizer's ADCETRIS Combo for Relapsed Lymphoma
Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application ...
Le Lézard22 小时
U.S. FDA Approves Pfizer's ADCETRIS® Combination Regimen for the treatment of Relapsed ...
Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for ADCETRIS® (brentuximab vedotin) in combination with ...